State MO
Clinical Trials in Missouri
Recruiting clinical trials with at least one study location in Missouri. Data updated daily from ClinicalTrials.gov.
Top Conditions in Missouri
NCT06959524 N/A
Recruiting
AGENT DCB STANCE: Safety and Effectiveness Study of AGENT Drug-Coated Balloon Co...
Condition
Coronary Arterial Disease (CAD)
Enrollment
1,616 pts
Location
United States, Australia, Germany
Sponsor
Boston Scientific Corporation
NCT04831580 N/A
Recruiting
A Trial of Robotic Versus Open Hysterectomy Surgery in Cervix Cancer
Condition
Cervical Cancer
Enrollment
840 pts
Location
United States, Canada
Sponsor
GOG Foundation
NCT05831579 N/A
Recruiting
Palliative Spatially Fractionated (GRID) Radiotherapy Using Intensity Modulated ...
Condition
Unresectable Solid Tumor
Enrollment
24 pts
Location
United States
Sponsor
Washington University School o
NCT06481891 Phase 3
Recruiting
A Study to Evaluate the Efficacy and Safety of Sotagliflozin in Symptomatic Obst...
Condition
Obstructive Cardiomyopathy, Hypertrophic
Enrollment
500 pts
Location
United States, Argentina, Belgium
Sponsor
Lexicon Pharmaceuticals
NCT06571474 N/A
Recruiting
Harnessing Macrophage Lysosomal Lipid Metabolism in Obesity (ATM)
Condition
Obesity
Enrollment
60 pts
Location
United States
Sponsor
Bettina Mittendorfer
NCT05334069 N/A
Recruiting
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests...
Condition
Acute Lymphoblastic Leukemia
Enrollment
2,000 pts
Location
United States
Sponsor
Alliance for Clinical Trials i
NCT05784246 Phase 3
Recruiting
A Study of Mirikizumab (LY3074828) in Pediatric Participants With Moderately to ...
Condition
Ulcerative Colitis
Enrollment
60 pts
Location
United States, Belgium, Canada
Sponsor
Eli Lilly and Company
NCT06780670 Phase 2, Phase 3
Recruiting
Open-label Study Comparing AAA817 Versus Standard of Care in the Treatment of Pr...
Condition
Prostate Cancer
Enrollment
443 pts
Location
United States, Australia, Brazil
Sponsor
Novartis Pharmaceuticals
NCT05703672 Phase 3
Recruiting
Switching to E-cigarettes in Smokers Not Interested in Quitting
Condition
Smoking Reduction
Enrollment
500 pts
Location
United States
Sponsor
University of Kansas Medical C
NCT03932786 N/A
Recruiting
Studying Health Outcomes After Treatment in Patients With Retinoblastoma
Condition
Retinoblastoma
Enrollment
900 pts
Location
United States, Canada
Sponsor
Vanderbilt-Ingram Cancer Cente
NCT06095583 Phase 3
Recruiting
Phase 3 Study of Toripalimab Alone or in Combination With Tifcemalimab as Consol...
Condition
Limited-stage Small Cell Lung Cancer (LS-SCLC)
Enrollment
756 pts
Location
United States, Belgium, China
Sponsor
Shanghai Junshi Bioscience Co.
NCT05006482 Phase 3
Recruiting
Geriatric Evaluation and Management With Survivorship Health Education for Older...
Condition
Lymphoma
Enrollment
668 pts
Location
United States
Sponsor
University of Rochester
NCT06456554 N/A
Recruiting
Acellular Dermal Matrix Investigation in Breast Reconstruction
Condition
Breast Reconstruction
Enrollment
467 pts
Location
United States
Sponsor
RTI Surgical
NCT05561127 Phase 3
Recruiting
Paclitaxel Coated Balloon for the Treatment of Chronic bEnigN sTricture- Bowel
Condition
Bowel; Stricture
Enrollment
171 pts
Location
United States
Sponsor
GIE Medical
NCT06045754 Phase 4
Recruiting
A Study of Vedolizumab Intravenous (IV) and Adalimumab or Vedolizumab and Usteki...
Condition
Crohn's Disease
Enrollment
100 pts
Location
United States, Canada
Sponsor
Takeda
NCT06999603 Phase 2
Recruiting
Phase 2 Study of Inhaled SNG001 in Mechanically Ventilated Patients With Respira...
Condition
Viral Pneumonia
Enrollment
550 pts
Location
United States, Belgium, France
Sponsor
Synairgen Research Ltd.
NCT04743141 Phase 3
Recruiting
Long-term Safety Study of Rimegepant in Pediatric Subjects for the Acute Treatme...
Condition
Acute Treatment of Migraine
Enrollment
600 pts
Location
United States, Poland, Spain
Sponsor
Pfizer
NCT06895070 N/A
Recruiting
XVIVO Heart Box (XHB) With Supplemented XVIVO Heart Solution (SXHS) Continued Ac...
Condition
Heart Transplant
Enrollment
60 pts
Location
United States
Sponsor
XVIVO Perfusion
NCT02422641 Phase 2
Recruiting
Prospective Evaluation Of High-Dose Systemic Methotrexate In Patients With Breas...
Condition
Metastatic Breast Cancer
Enrollment
16 pts
Location
United States
Sponsor
Wake Forest University Health
NCT06997029 Phase 1
Recruiting
A Phase 1 Study of BMS-986500 as Monotherapy or Combination Therapy in Advanced ...
Condition
Advanced Solid Tumor
Enrollment
234 pts
Location
United States, Denmark, Japan
Sponsor
Bristol-Myers Squibb
NCT06286761 N/A
Recruiting
Routine Validation and Reproducibility Testing of Laboratory Measures and Resear...
Condition
Obesity
Enrollment
100 pts
Location
United States
Sponsor
Bettina Mittendorfer
NCT06795022 Phase 1, Phase 2
Recruiting
First in Human Study to Evaluate AZD9793 in Participants With Advanced or Metast...
Condition
Hepatocellular Carcinoma
Enrollment
304 pts
Location
United States, China, Hong Kong
Sponsor
AstraZeneca
NCT00345553 N/A
Recruiting
Biliary Atresia Study in Infants and Children
Condition
Biliary Atresia
Enrollment
1,265 pts
Location
United States, Canada
Sponsor
Arbor Research Collaborative f
NCT06356571 Phase 2
Recruiting
A Study to Investigate Subcutaneous Isatuximab in Combination With Weekly Carfil...
Condition
Plasma Cell Myeloma Refractory
Enrollment
64 pts
Location
United States
Sponsor
Sanofi
NCT04870944 Phase 1, Phase 2
Recruiting
CBL0137 for the Treatment of Relapsed or Refractory Solid Tumors, Including CNS ...
Condition
Diffuse Midline Glioma, H3 K27-Altered
Enrollment
63 pts
Location
United States, Australia
Sponsor
Children's Oncology Group